Henan Cancer Hospital: all 234 studies
Page 1 of 3. Open to participants first (130), then studies with results posted, then the rest; newest registration first within each.
- Exploring Curative Model for Advanced Breast Cancer: a Single-center, Prospective Phase II Clinical StudyNot yet recruitingNCT07888556
- Trastuzumab Combined With Retlirafusp Alfa in Treating HER2（Human Epidermal Growth Factor Receptor 2） 2+/3+ Gastric/Gastroesophageal Junction Adenocarcinoma After First-line Systemic Therapy FailureNot yet recruitingNCT07817654Phase 2
- Evaluating Safety ,Tolerability, Pharmacokinetic,Efficacy of WJ01024 or WJ01024 Combined With Ruxolitinib in Patients With MyelofibrosisRecruitingNCT07802405Phase 1
- Neoadjuvant Chemoradiotherapy Versus Neoadjuvant Immunochemotherapy for Resectable Esophageal Cancer: A Target Trial Emulation StudyNot yet recruitingNCT07778056
- AI-Driven Digital Twin and Drug Simulation for Esophageal CancerNot yet recruitingNCT07757022
- Tolerability of Dalpiciclib vs. Abemaciclib/Ribociclib in Early HR+/HER2- Breast CancerNot yet recruitingNCT07706933Not applicable
- Safety and Efficacy of Intrathecal Sacituzumab Tirumotecan for Leptomeningeal Metastasis in EGFR-TKI-Resistant Non-Small Cell Lung CancerNot yet recruitingNCT07702305Phase 1
- Toripalimab Combined With Beat Chemotherapy in the Treatment of Advanced Back-line Small Cell Lung CancerNot yet recruitingNCT07698054Phase 2
- Lisaftoclax Plus Pirtobrutinib in Relapsed or Refractory Mantle Cell Lymphoma After BTK-Targeted TherapyNot yet recruitingNCT07684950Phase 2
- Surgery vs. Radical Chemoradiotherapy for Esophageal SCC After Neoadjuvant ImmunochemotherapyRecruitingNCT07629817Phase 3
- A Multicenter, Randomized, Open-label, Controlled Study of HAIC Combined With Camrelizumab and Apatinib Mesylate for Perioperative Treatment of Resectable Hepatocellular Carcinoma With High-risk Recurrence FactorsNot yet recruitingNCT07618546Not applicable
- Retlirafusp Alfa Combined With Apatinib and Nab-Paclitaxel as Second-line Treatment for Gastric or Gastroesophageal Junction CancerNot yet recruitingNCT07610629Phase 2
- A Multicenter, Open-label, Randomized, Prospective Clinical Study of Adebrelimab Consolidation Therapy for Limited-Stage Small-Cell Lung Cancer (LS-SCLC) Without Progression After Concurrent ChemoradiotherapyRecruitingNCT07559786Phase 2
- Exploration of the Application of Methotrexate-loaded Drug Vesicles in Intrathecal Injection for Meningeal Metastasis of Lung CancerRecruitingNCT07559097Phase 1/2
- A Multicohort Study of Toripalimab in Combination With Investigator-Selected Chemotherapy for Advanced HER2-Negative Breast CancerRecruitingNCT07540533Phase 2
- CD20 Monoclonal Antibody-Based First-Line Therapy in Treatment-Naive Marginal Zone B-Cell LymphomaNot yet recruitingNCT07492407
- Real-World Effectiveness and Safety of Glofitamab in Primary Refractory and Early Relapsed Diffuse Large B-Cell LymphomaNot yet recruitingNCT07472621
- Efficacy and Safety of Lisaftoclax (APG-2575) Monotherapy in Patients With Mature B-cell LymphomaNot yet recruitingNCT07459608Phase 2
- A Cohort Study on the Prevention of Nausea and Vomiting Induced by Concurrent Chemoradiotherapy for Lung Cancer Using Rolapitant and PalonosetronNot yet recruitingNCT07442890Not applicable
- Trastuzumab Rezetecan vs Trastuzumab Deruxtecan in the Neoadjuvant Treatment of HER2 Positive Breast CancerNot yet recruitingNCT07416253Phase 2
- Anlotinib in Cross-line Treatment of NSCLC and SCLCNot yet recruitingNCT07400575
- Efficacy and Safety of Radiotherapy Combined With Tislelizumab and Anlotinib in the Treatment of Hepatocellular Carcinoma Complicated With Portal Vein Tumor ThrombusNot yet recruitingNCT07363512Phase 2
- Fruquintinib Combined With Trastuzumab and XELOX as First-line Treatment in Patients With HER2-positive Advanced Gastric CancerRecruitingNCT07334431Phase 1/2
- Application of Toripalimab as Adjuvant Therapy After Esophageal Cancer Surgery: A Multicenter Clinical TrialNot yet recruitingNCT07332221Phase 3
- Evaluate the Safety, Tolerability, Biodistribution Characteristics and Preliminary Efficacy of BioTTT001RecruitingNCT07264569Phase 1/2
- Toripalimab Combined With Anthracycline-free or Anthracycline-containing Chemotherapy as Neoadjuvant Chemotherapy for Early Triple Negative Breast CancerNot yet recruitingNCT07256964Phase 2
- Clinical Study on Using TCR to Predict the Effect of Tislelizumab + Chemotherapy in the First-line Treatment of ES-SCLCRecruitingNCT07244016
- Zanubrutinib Combined With Rituximab in the Treatment for Patients With Marginal Zone LymphomaRecruitingNCT07233720
- Development and Application of AI-Based Therapeutic Strategies for Esophageal Cancer Integrating Multimodal Imaging and Digital PathologyNot yet recruitingNCT07203690
- Efbemalenograstim Alfa for Primary/Secondary Prevention in Patients With Solid Tumors at High Risk for Febrile Neutropenia (FN) or Intermediate Risk of Chemotherapy Regimens Associated With Other Risk Factors in FNRecruitingNCT07187908Phase 2
- Efficacy of TQB2102 Versus TCbHP in Neoadjuvant Therapy for HER2-positive Early Breast Cancer.Not yet recruitingNCT07136974Phase 2
- SHR2554 Combined With Endocrine Therapy in Advanced Breast CancerRecruitingNCT07125950Phase 2
- A Single-center, Phase II Clinical Trial Evaluating the Efficacy of Sacituzumab Tirumotecan in Combination With Tagitanlimab as Neoadjuvant Therapy for PD-L1-positive, Resectable Stage II to IIIB Non-small Cell Lung Cancer (NSCLC)Not yet recruitingNCT07108816Phase 2
- Trastuzumab Rezetecan Combined With Radiotherapy Versus Trastuzumab Rezetecan in the Treatment of HER2-positive Advanced Breast Cancer With Brain MetastasesRecruitingNCT07100600Phase 2
- Efficacy of Nab-PHP Versus TCbHP in Neoadjuvant Therapy for HER2-positive Early Breast CancerRecruitingNCT07057427Phase 3
- Trastuzumab Rezetecan Plus Pertuzumab in the Neoadjuvant Treatment of HER2 Positive BCNot yet recruitingNCT07047755Phase 2
- Efficacy and Safety of Prepectoral Prosthesis Immediate One-Stage Breast Reconstruction Versus Two-Stage Expander/Prosthesis Reconstruction in Postoperative Adjuvant Radiotherapy Breast Cancer Patients: A Prospective, Single-Center, Cohort StudyRecruitingNCT07037576
- Evaluation of the Effectiveness and Safety of Laparoscopic Assisted Mastectomy With Preservation of Nipple and Areola, Immediate One-step Breast Reconstruction With Pectoral Muscle Prosthesis and Patch, and Simultaneous Autologous Fat TransplantationRecruitingNCT07037537Not applicable
- QL1706 for the Neoadjuvant Treatment of HR+/HER2- Breast CancerRecruitingNCT06967103Phase 2
- Organoid-guided Personalized Treatment of Pleural EffusionRecruitingNCT06959173
- Clinical Trial of HRS-4642 Plus SHR-A2102 in Patients With Advanced Solid TumorsNot yet recruitingNCT06955390Phase 1/2
- A Clinical Trial of Furmonertinib Combined With Anlotinib as First-line Treatment for Advanced NSCLC With EGFR-sensitive Mutations and Brain MetastasisRecruitingNCT06945705Phase 2
- The Efficacy of Oral Cryotherapy in Preventing TROP2-ADC-Induced Oral Mucositis in Patients With Advanced Breast CancerNot yet recruitingNCT06934733Not applicable
- SHR-A1811 Plus Pertuzumab in the Neoadjuvant Treatment of HER2 Positive BCRecruitingNCT06927180Phase 2
- Real World Study of Oxycodone/Naloxone Sustained-Release Tablets (Mimeixin) for Patients With Severe Cancer PainNot yet recruitingNCT06897917Phase 4
- Serplulimab Combined With Chemotherapy for Early-stage HR+/HER2- Breast CancerRecruitingNCT06860529Phase 2
- Evaluation of Neoadjuvant Therapy Efficacy and Postoperative Pathological Indicators in Esophageal Cancer Using CT and Multimodal MRINot yet recruitingNCT06833775
- SHR-A2102 Combined With Adebrelimab as Neoadjuvant Therapy for Early Triple-Negative Breast CancerNot yet recruitingNCT06819319Phase 2
- Mechanistic Study on the Diagnosis of Esophageal Cancer Lymph Node Metastasis Using Spectral CT, Multimodal MRI, FAPI PET-CT, Pathology, and AI Evaluation SystemNot yet recruitingNCT06818214
- Nab-P+Cb+PD1 Inhibitors as Neoadjuvant Therapy for Early TNBCRecruitingNCT06817525Phase 2
- Nanocrystalline Megestrol + Immunochemo As 1st-Line for ES-SCLC CachexiaNot yet recruitingNCT06793228Phase 2
- A Study of SHR-A1811 and Fulvestrant, With or Without HS-10352, in Locally Advanced or Metastatic Breast Cancer PatientsNot yet recruitingNCT06788197Phase 1/2
- Real-world Study of Sunvozertinib Treatment in Advanced EGFR-Mutant NSCLC After EGFR-TKI Treatment FailureNot yet recruitingNCT06786208
- NabPE With or Without Serplulimab for Early-stage HR+/HER2- Breast Cancer.RecruitingNCT06781281
- A Study of Fruquintinib Plus Chemotherapy for Postoperative Treatment of HER2-Negative Gastric Cancer With Poor TRGRecruitingNCT06774222Phase 2
- Adebrelimab Combined with Apatinib and Gemcitabine and Cisplatin (GP) First-line Treatment for Unresectable Biliary Tract CarcinomaRecruitingNCT06749730Phase 2
- Sequential T and I With H101 Via HAI for BCLC C Stage HCC: A Prospective Single-Center Single-Arm Pilot StudyNot yet recruitingNCT06685354Phase 2
- ARX788 in HER2-positive Metastatic Breast Cancer PatientsRecruitingNCT06663748Phase 2
- Evaluating High-dose Furmonertinib with Bevacizumab and Pemetrexed for EGFRm NSCLC with Leptomeningeal MetastasisRecruitingNCT06643000Not applicable
- Local Injection and Systemic Therapy in the Treatment of NSCLC.Not yet recruitingNCT06618391Phase 2
- To Evaluate the Efficacy and Safety of Ipsilateral Supraclavicular Lymph Node Dissection for Breast Cancer PatientsRecruitingNCT06605521
- A Single-arm, Prospective Phase Ⅱ Clinical Study of Utidelone Combined With Capecitabine in the Treatment of Active Brain Metastasis of TNBCRecruitingNCT06598046Phase 2
- Tislelizumab and Induction Chemotherapy for Larynx Preservation in Resectable Advanced Laryngeal/Hypopharyngeal CancerNot yet recruitingNCT06554028Phase 2
- RE002 T Cell Injection for the Treatment of KRAS G12D Mutated Solid TumorsRecruitingNCT06546150Phase 1
- RE001 T Cell Injection for the Treatment of KRAS G12V Mutated Solid TumorsNot yet recruitingNCT06545201Phase 1
- Axillary Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Patients With Initial cN1 Breast CancerRecruitingNCT06518135
- Backline Treatment of Advanced Hepatocellular Carcinoma With PalbociclibRecruitingNCT06478927Not applicable
- L218CAR19 in Patients With Relapsed/Refractory B-cell LymphomaRecruitingNCT06478381Phase 1
- Efficacy of Pyrotinib Plus Capecitabine in HER2-positive MBC With Active Brain Metastases That Have Failed ADCsNot yet recruitingNCT06475443Phase 2
- Clinical Study of SHR-A1921 or SHR-A2009 in Previously Treated Advanced NSCLCNot yet recruitingNCT06465238Phase 2
- Clinical Study of Trop2 CAR-NK in the Treatment of Relapsed/Refractory Non-Small Cell Lung Cancer (NSCLC)Not yet recruitingNCT06454890Phase 1/2
- An Exploratory Study of Efficacy and Safety of Iruplinalkib Tablets in Patients With ROS1 Positive Non-small Cell Lung CancerRecruitingNCT06436885Early Phase 1
- This is a Phase II, Open-label, Multicentre Study of Zanubrutinib-containing Regimens in Patients With Newly Diagnosed Mantle Cell LymphomaNot yet recruitingNCT06427213Phase 2
- A Phase II Clinical Study of Cadonilimab in Treatment-naïve or Relapsed Extensive Small Cell Lung CancerRecruitingNCT06406673Phase 2
- Patient-derived Organoid Drug Sensitivity Guided Treatment for Recurrent Small Cell Lung CancerRecruitingNCT06406660Not applicable
- Patient-derived Organoid Drug Sensitivity Guided Treatment for Drug-resistant Recurrent Non-Small Cell Lung CancerRecruitingNCT06406608Not applicable
- the Prevention of Bone Marrow Suppression Caused by Chemotherapy in Advanced NSCLC With TrilaciclibEnrolling by invitationNCT06370416Phase 2
- PD1 Antibody Combined With mFOLFOX6 Neoadjuvant Therapy for Advanced Resectable Metastatic Colon CancerNot yet recruitingNCT06335147Not applicable
- Serplulimab Plus Bevacizumab and Chemotherapy for EGFR-mutant Metastatic NSCLC Patients After EGFR-TKI Treatment FailureRecruitingNCT06334757Phase 2
- Fruquintinib in Combination With Sintilimab and CAPEOX as First-line Treatment for G/GEJ CancerRecruitingNCT06329973Phase 1/2
- TAS-102 Combined With Bevacizumab for Second-line Maintenance Treatment of Advanced Colorectal CancerRecruitingNCT06293014Phase 2
- Tace With Icaritin in First-line Treatment of Middle and Advanced HCC in Child Grade B PatientsNot yet recruitingNCT06285149Phase 2
- Darsilide Combined With AI, Trastuzumab and Patuzumab in the Neoadjuvant Treatment of HR+/HER2+ Breast CancerRecruitingNCT06276868Phase 2
- A Multicenter, Real-world Study of Adebrelimab in the Treatment of Extensive Stage Small Cell Lung CancerNot yet recruitingNCT06267170
- The Maintenance Treatment of "ITIVA" in AML PatientsRecruitingNCT06256627Not applicable
- Adebrelimab and Concurrent Radiochemotherapy as First-line Treatment for Extensive-stage Small-cell Lung CancerNot yet recruitingNCT06236997Phase 2
- Thalidomide Prevention or Treatment of Camrelizumab-induced Reactive Cutaneous Capillary Endothelial Proliferation (RCCEP)RecruitingNCT06231680Phase 2
- Disitamab Vedotin Combined With Sintilimab and XELOX Perioperative Treatment for Resectable Gastric Caner With HER2 OverexpressionNot yet recruitingNCT06227325Phase 2
- Combination Followed by Maintenance Chemotherapy Versus CDK4/6 Inhibitor Combined With Endocrine Therapy for HR Low/HER2-negative Advanced Breast Cancer: a Prospective, Randomized, Open-label Phase Ⅱ Clinical TrialRecruitingNCT06176534Phase 2
- The Safety and Efficacy of Double-target CART-19 and 20 Cells in Non-Hodgkin's Lymphoma (NHL)RecruitingNCT06160362Not applicable
- Go-CHOP as the Frontline Therapy for PTCLRecruitingNCT05963347Phase 2
- Real World Study of Oxycodone Sustained-release Tablets for Patients With Moderate to Severe Cancer PainRecruitingNCT05962294
- Comparing the Efficacy of Nab-PH+Pyrrolitinib and TCbHP in the Neoadjuvant Treatment of HER2 Positive BCRecruitingNCT05918328Phase 2
- A Study of SHR-A1811 as Neoadjuvant Treatment for Patients With HR-Positive, Low HER2 Expression Breast CancerRecruitingNCT05911958Phase 2
- Efficacy and Safety of SHR0302 in Patients With Relapsed/Refractory Peripheral T/NK Cell LymphomaNot yet recruitingNCT05900089Phase 1
- Carrilizumab Combined With White Purple for Squamous Cell Carcinoma of SkinRecruitingNCT05886140Not applicable
- Study of SHR-A1811 in HER2-expression Advanced Breast Cancer With Brain MetastasesRecruitingNCT05769010Phase 2
- Piamprilizumab (AK105) Combined With Radiotherapy for Neoadjuvant Treatment of Soft Tissue SarcomaRecruitingNCT05718778Not applicable
- Hydroxychloroquine Combined With Gemcitabine in the Treatment of Advanced Non-small Cell Lung CancerNot yet recruitingNCT05647330Phase 2
- Assessment of Safety and Efficacy of ThisCART19A in Adult Patients With B Cell Malignancies After Failure of Autologous Chimeric Antigen Receptor T- Cell(CAR-T) TherapyNot yet recruitingNCT05640713Phase 1